Rafferty Asset Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-60,614
Closed -$1.13M 1171
2024
Q2
$1.13M Sell
60,614
-80,249
-57% -$1.5M ﹤0.01% 789
2024
Q1
$2.78M Buy
140,863
+45,008
+47% +$879K 0.01% 607
2023
Q4
$1.68M Sell
95,855
-43,251
-31% -$711K 0.01% 716
2023
Q3
$2.42M Buy
139,106
+19,731
+17% +$332K 0.01% 560
2023
Q2
$1.68M Sell
119,375
-9,913
-8% -$133K 0.01% 690
2023
Q1
$1.39M Buy
129,288
+37,976
+42% +$500K 0.01% 714
2022
Q4
$1.37M Buy
+91,312
New +$1.33M 0.01% 681
2022
Q1
Sell
-88,024
Closed -$1.04M 1279
2021
Q4
$1.04M Buy
88,024
+1,819
+2% +$22.4K 0.01% 847
2021
Q3
$982K Sell
86,205
-16,876
-16% -$220K 0.01% 829
2021
Q2
$1.44M Buy
103,081
+38,673
+60% +$587K 0.01% 776
2021
Q1
$1.19M Buy
64,408
+47,641
+284% +$974K 0.01% 732
2020
Q4
$296K Buy
+16,767
New +$295K ﹤0.01% 812

Other funds holding KNSA